Vision
CREATING A WORLD WHERE SELF-HEALING IS “THE” STANDARD OF CARE.Mission
To provide regenerative technologies that dramatically improves the current standard of care.We will be most admired for our INNOVATION, TECHNOLOGY, TRAINING and SUPPORT.
Case Study
Published in the Journal of Pain Research, here is a case series that discusses the licensed stem cell protocol used by VivaTech USA.
Our Company
VivaTech is a Pennsylvania-registered Corporation that licenses proprietary technology utilizing ultrasound cavitation to extract the adipose-StroMed cells with extra-cellular matrix from adipose tissue. Unlike other methods of stem cell therapy, the major advantages of using this patented technology is the ease and speed of processing (minutes instead of hours) and most importantly, NO USE OF ENZYMES or chemicals.VivaTech will license the ultrasonic cavitation technology, using Adipose-derived (StroMed), to Medical Doctors throughout North America for use in patients under approved Institutional Review Board protocols. VivaTech will license stem cell therapies for diseases that are poorly treated with the current standard of care. The company is currently engaged in clinical studies to investigate how this proprietary technology will regenerate cartilage and reduce pain and inflammation in degenerated tissue.
Advanced Pain Medicine was the first clinic to begin our Institutional Review Board-Regulated clinical trials.
More Info
